CBD Life Sciences Inc. (CBDL)

0.0001 +0.0001 (+9,900.00%) At close: 02:16PM EDT

CBD Life Sciences Inc.

10855 N 116th Street
Suite 115
Scottsdale, AZ 85259
United States
480 410 6780
https://lbcbioscienceinc.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 4

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Lisa Anne Nelson	CEO, President, CFO, Secretary, Treasurer & Director	240k	N/A	1967
Mr. Matthew McGee	Chief Marketing Officer	57.6k	N/A	2000
Ms. Brianna Nelson	Chief Product Developer & Director	84k	N/A	1997

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Corporate governance

CBD Life Sciences Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.